The HONEST Cohort Study
Open Access
- 25 March 2026
- journal article
- Published by Elsevier in JACC: Advances
- Vol. 5 (3) , 102604
Abstract
No abstract availableKeywords
Funding Information
- Société Française de Cardiologie
- Institut National de la Santé et de la Recherche Médicale
- U.S. Food and Drug Administration
This publication has 33 references indexed in Scilit:
- Seattle proportional risk model in GISSI-HF: Estimated benefit of ICD in patients with EF less than 50%American Heart Journal, 2024
- Subcutaneous Implantable Cardioverter-Defibrillators in Patients With Congenital Heart DiseaseJACC, 2023
- Postapproval Study of a Subcutaneous Implantable Cardioverter-Defibrillator SystemJACC, 2023
- Pitfalls of the S-ICD therapy: experiences from a large tertiary centreClinical Research in Cardiology, 2020
- Oversensing issues leading to device extraction: When subcutaneous implantable cardioverter-defibrillator reached a dead-endHeart Rhythm, 2020
- Subcutaneous implantable cardioverter defibrillator implantation: An analysis of Italian clinical practice and its evolutionInternational Journal of Cardiology, 2018
- Subcutaneous implantable cardioverter-defibrillator Post-Approval Study: Clinical characteristics and perioperative resultsHeart Rhythm, 2017
- Shock efficacy of the entirely subcutaneous defibrillator for termination of spontaneous ventricular fibrillation in Brugada syndromeHeart Rhythm, 2013
- Cardiac device infections are associated with a significant mortality riskHeart Rhythm, 2012
- Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failureHeart Rhythm, 2009